| 17.4 0.2 (1.16%) | 01-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.89  |
1-year : | 24.4 |
| Resists | First : | 17.88 |
Second : | 20.89 |
| Pivot price | 17.33 |
|||
| Supports | First : | 17.06 |
Second : | 16.55 |
| MAs | MA(5) : | 17.41  |
MA(20) : | 17.23 |
| MA(100) : | 16.73 |
MA(250) : | 20.05 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 53.7 |
D(3) : | 60.7 |
| RSI | RSI(14): 53.6 |
|||
| 52-week | High : | 25.17 | Low : | 14.02 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ KVUE ] has closed below upper band by 44.1%. Bollinger Bands are 50.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.49 - 17.61 | 17.61 - 17.71 |
| Low: | 16.85 - 17 | 17 - 17.13 |
| Close: | 17.17 - 17.4 | 17.4 - 17.62 |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Fri, 30 Jan 2026
Jefferies downgrades Kenvue stock to Hold on limited upside after merger vote - Investing.com
Thu, 29 Jan 2026
Kenvue shareholders overwhelmingly approve Kimberly-Clark merger plan - TipRanks
Thu, 29 Jan 2026
Peering Into Kenvue Inc's Recent Short Interest - Benzinga
Thu, 29 Jan 2026
Kimberly-Clark and Kenvue shareholders approve acquisition deal - Investing.com
Thu, 29 Jan 2026
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue - PR Newswire
Thu, 29 Jan 2026
Kenvue Inc. $KVUE Position Trimmed by Bank of New York Mellon Corp - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 1,920 (M) |
| Shares Float | 1,910 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 98.8 (%) |
| Shares Short | 81,100 (K) |
| Shares Short P.Month | 64,470 (K) |
| EPS | 0.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.55 |
| Profit Margin | 9.5 % |
| Operating Margin | 19.2 % |
| Return on Assets (ttm) | 6.8 % |
| Return on Equity (ttm) | 13.4 % |
| Qtrly Rev. Growth | -3.5 % |
| Gross Profit (p.s.) | 4.55 |
| Sales Per Share | 7.81 |
| EBITDA (p.s.) | 1.84 |
| Qtrly Earnings Growth | 3.7 % |
| Operating Cash Flow | 2,140 (M) |
| Levered Free Cash Flow | 1,750 (M) |
| PE Ratio | 23.19 |
| PEG Ratio | 0 |
| Price to Book value | 3.13 |
| Price to Sales | 2.22 |
| Price to Cash Flow | 15.61 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 1.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |